Unique FISH patterns associated with cancer progression of oral dysplasia

Journal of Dental Research

Volumn 91, Issue 1, 2012, Pages 52-57

  Poh, C F ^a,b   Zhu, Y ^a   Chen, E ^a   Berean, K W ^a   Wu, L ^a   Zhang, L ^a   Rosin, M P ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

CCND1; chromosomal instability; EGFR; fluorescent in situ hybridization; oral dysplasia; progression

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; CASE CONTROL STUDY; CELL TRANSFORMATION; CENTROMERE; CHROMOSOMAL INSTABILITY; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; POLYPLOIDY; PRECANCER; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CENTROMERE; CHROMOSOMAL INSTABILITY; CYCLIN D1; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; POLYPLOIDY; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 83455235876     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511425676     Document Type: Article

References (30)

1. Axéll T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden. ; 1996 1994 ; 1996 1994. 49.
2. Bergshoeff VE, Hopman AH, Zwijnenberg IR, Ramaekers FC, Bot FJ, Kremer B, et al. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J Pathol. 2008 ; 215: 347-348 (Pubitemid 351956716)
3. Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol. 2006 ; 18: 228-233 (Pubitemid 43740416)
4. Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, et al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol. 2005 ; 23: 5007-5018 (Pubitemid 46224007)
5. Egloff AM, Grandis JR. Improving response rates to EGFR-targeted therapies for head and neck squamous cell carcinoma: candidate predictive biomarkers and combination treatment with Src inhibitors. J Oncol. 2009 ; 2009: 896407
6. Epstein JB, Gorsky M, Cabay RJ, Day T, Gonsalves W. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians. Can Fam Physician. 2008 ; 54: 870-875 (Pubitemid 352045138)
7. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL. OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol. 2004 ; 40: 511-519 (Pubitemid 38296837)
8. Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, et al. Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer. 2009 ; 8: 50
9. Grandis JR. Prognostic biomarkers in head and neck cancer. Clin Cancer Res. 2006 ; 12: 5005-5006
10. Hirsch FR, Varella-Garcia M, Bunn PA, Di Maria MV, Veve R, Bremmes RM, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003 ; 21: 3798-3807 (Pubitemid 46606235)
11. Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Intriguing issues of EGFR targeting in head and neck cancer. Ann Oncol. 2007 ; 18: 962 (Pubitemid 47054099)
12. Kuo MY, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 1999 ; 28: 165-169 (Pubitemid 29174803)
13. Langer CJ. Cancer. 2008 2007 ; 112: 2635-2645
14. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 1994 ; 91: 9871-9875 (Pubitemid 24311910)
15. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1997 ; 123: 497-502
16. Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y, Amagasa T. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer. 2005 ; 104: 2709-2716 (Pubitemid 41798281)
17. Romeo MS, Sokolova IA, Morrison LE, Zeng C, Baron AE, Hirsch FR, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn. 2003 ; 5: 103-112 (Pubitemid 36553430)
18. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000 ; 6: 357-362 (Pubitemid 30111451)
19. Ryott M, Wangsa D, Heselmeyer-Haddad K, Lindholm J, Elmberger G, Auer G, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer. 2009 ; 45: 1700-1708
20. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998 ; 34: 270-275 (Pubitemid 28318253)
21. Sheu JJ, Hua CH, Wan L, Lin YJ, Lai MT, Tseng HC, et al. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma. Cancer Res. 2009 ; 69: 2568-2576
22. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol. 2002 ; 38: 235-243 (Pubitemid 34442544)
23. Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck. 2002 ; 24: 874-887
24. Temam S, Kawaguchi H, El-Naggar AK, Jelinek J, Tang H, Liu DD, et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol. 2007 ; 25: 2164-2170 (Pubitemid 46954638)
25. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002 ; 13: 51-61 (Pubitemid 34792760)
26. Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol. 2009 ; 45: 468-473
27. Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL. Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias. Int J Cancer. 2009 ; 125: 2219-2228
28. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study [of] 3256 oral leukoplakias. Cancer. 1975 ; 36: 1386-1392
29. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009 ; 45: 309-316
30. Weaver BA, Cleveland DW. Does aneuploidy cause cancer?. Curr Opin Cell Biol. 2006 ; 18: 658-667 (Pubitemid 44692476)